Skip to content
DraconiticResearch
Search Sources API
194,230 studies31 sourcesUpdated 57 min ago
Peer-reviewedCC BY 4.0ACS Omega

Erythrosine–Iron Oxide Nanoemulsions Combining Photodynamic Therapy with Ferroptosis-Mediated Cytotoxicity in Prostate Cancer

  1. 1São Paulo State University (UNESP) , , , ,

Abstract

Prostate cancer remains one of the leading causes of cancer-related death among men worldwide. Photodynamic therapy (PDT) has emerged as a promising strategy to enhance conventional treatments, yet its efficacy is often limited by poor solubility, instability, and a lack of targeting of photosensitizers. Here, we report the development of hybrid erythrosine–iron oxide nanoemulsions (MNE/Ery) produced by vacuum-assisted nanoemulsification. The optimized formulation (0.05 mg·mL–1 erythrosine; 0.5 mg·mL–1 maghemite) exhibited a hydrodynamic diameter of ∼100 nm, negative surface charge, and strong retention of the photosensitizer’s spectral profile. The iron oxide nanoparticles (20–30 nm) exhibited efficient magnetic heating potential, reaching 42 °C within 5.5 min under an alternating field (418 kHz, 12 kA·m–1), indicating suitability for future exploration in magnetic hyperthermia applications. While MNE/Ery maintained high biocompatibility toward healthy cells (HDFn and PNT2), it induced a potent light-triggered cytotoxic response in PC-3 prostate cancer cells. Upon irradiation, the platform delivered a robust, dose-dependent therapeutic effect even at conservative fluences, driven by the combination of maghemite-induced oxidative stress (ferroptosis) and erythrosine-mediated ROS generation. These findings position the MNE/Ery system as a promising nanotechnological platform for PDT with an intrinsic iron-mediated chemotherapeutic effect, with additional potential for future magnetic hyperthermia-based applications.

Related

  1. Rational design of O/W nanoemulsions based on the surfactant dodecyldiglyceryl ether using the normalized HLD concept and the formulation-composition map
    Lucie Delforce, Jesús Ontiveros, Véronique Nardello-Rataj +1
    Colloids and Surfaces A: Physicochemical and Engineering AspectsPeer-reviewedLicence not stated12 citedOrganic chemistryHAL
  2. Interaction effects and droplet dynamics in chitosan-coated nanoemulsions via echo-Diffusing Wave Spectroscopy
    Logan-Marie Torry, Foluso Akin-Ige, Jose Huergo +3
    ChemRxivPreprintCC BYFull textGeneral chemistryChemRxiv
  3. Physicochemical Stability and In Vitro Antifungal Activity of Mentha spicata Essential Oil and L-Carvone Nanoemulsions Against Stromatinia cepivora and Sclerotinia sclerotiorum
    Rodrigo Ribeiro Rocha, Lorena Alves de Melo Bessa, Geraldo Humberto Silva
    MoleculesPeer-reviewedCC BY 4.0General chemistryCrossref
  4. Optimization of Orange Peel Extract Nanoemulsions and Their Incorporation into Chitosan/Gelatin Biodegradable Films: Physicochemical and Functional Properties
    Nallely Peñuñuri-Pacheco, Nuria Muñoz-Tébar, Raquel Lucas-González +4
    PolymersPeer-reviewedCC BY 4.0Full textMaterials & polymersCrossrefEurope PMC
  5. A Vanadium(II) Photosensitizer Delivered by Human Serum Albumin for Photodynamic Therapy
    Zisis Papadopoulos, Aimée Marie Irgel, Alexandra König +2
    ChemRxivPreprintLicence not statedGeneral chemistryChemRxiv
BibTeX
@article{ferreira2026erythrosineiron,
  title = {{Erythrosine–Iron Oxide Nanoemulsions Combining Photodynamic Therapy with Ferroptosis-Mediated Cytotoxicity in Prostate Cancer}},
  author = {Matheus Liberato Ferreira and Giovanna Capaldi Fortunato and Rodolfo Debone Piazza and Marlus Chorilli and Fernando Lucas Primo},
  journal = {ACS Omega},
  year = {2026},
  month = oct,
  doi = {10.1021/acsomega.6c05709},
  url = {https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c05709/5453980/Erythrosine-Iron-Oxide-Nanoemulsions-Combining},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Erythrosine–Iron Oxide Nanoemulsions Combining Photodynamic Therapy with Ferroptosis-Mediated Cytotoxicity in Prostate Cancer
AU  - Matheus Liberato Ferreira
AU  - Giovanna Capaldi Fortunato
AU  - Rodolfo Debone Piazza
AU  - Marlus Chorilli
AU  - Fernando Lucas Primo
PY  - 2026
DA  - 2026/10/19
JO  - ACS Omega
DO  - 10.1021/acsomega.6c05709
UR  - https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c05709/5453980/Erythrosine-Iron-Oxide-Nanoemulsions-Combining
AB  - Prostate cancer remains one of the leading causes of cancer-related death among men worldwide. Photodynamic therapy (PDT) has emerged as a promising strategy to enhance conventional treatments, yet its efficacy is often limited by poor solubility, instability, and a lack of targeting of photosensitizers. Here, we report the development of hybrid erythrosine–iron oxide nanoemulsions (MNE/Ery) produced by vacuum-assisted nanoemulsification. The optimized formulation (0.05 mg·mL–1 erythrosine; 0.5 mg·mL–1 maghemite) exhibited a hydrodynamic diameter of ∼100 nm, negative surface charge, and strong retention of the photosensitizer’s spectral profile. The iron oxide nanoparticles (20–30 nm) exhibited efficient magnetic heating potential, reaching 42 °C within 5.5 min under an alternating field (418 kHz, 12 kA·m–1), indicating suitability for future exploration in magnetic hyperthermia applications. While MNE/Ery maintained high biocompatibility toward healthy cells (HDFn and PNT2), it induced a potent light-triggered cytotoxic response in PC-3 prostate cancer cells. Upon irradiation, the platform delivered a robust, dose-dependent therapeutic effect even at conservative fluences, driven by the combination of maghemite-induced oxidative stress (ferroptosis) and erythrosine-mediated ROS generation. These findings position the MNE/Ery system as a promising nanotechnological platform for PDT with an intrinsic iron-mediated chemotherapeutic effect, with additional potential for future magnetic hyperthermia-based applications.
SN  - 2470-1343
ER  -